Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02982954 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer (CHECKMATE 920) |
| First Submitted : | December 2, 2016 |
| First Submitted that Met QC Criteria : | December 2, 2016 |
| First Posted : | December 6, 2016 (Estimate) |
| Results First Submitted : | May 4, 2021 |
| Results First Submitted that Met QC Criteria : | September 17, 2021 |
| Results First Posted : | October 14, 2021 |
| Last Update Submitted that Met QC Criteria : | October 6, 2022 |
| Last Update Posted : | November 1, 2022 |